Medicover AB (publ) logo

Medicover AB (publ)

MCOV-B.ST
50
Medical - Care Facilities · Healthcare
Price
kr 214.00
+3.00 (+1.42%)
Market Cap
kr 32.31B
Exchange
Stockholm Stock Exchange
Winston Score
50
Winston looking curious
Winston is curious
Mixed quality — meaningful strengths and weaknesses.

Winston Score between 40 and 70. The stock passes some quality checks but not all.

Medicover is a healthcare company that runs hospitals, clinics, and diagnostic labs across Europe and India. It serves everyday patients who need doctor visits, medical tests, blood work, and hospital care. The company operates under the Medicover brand and is one of the larger private healthcare networks in Central and Eastern Europe.

Medicover makes money by charging patients and insurance companies for medical services and lab tests. It operates in over 15 countries, with a strong presence in Poland, Germany, Romania, and India, and generates roughly €1.8 billion in annual revenue. Its main competitive advantage is its dense network of clinics and labs, which is hard and expensive for new competitors to replicate. The key growth driver is rising demand for private healthcare in emerging European markets, where public health systems are often overcrowded. The main risk is that thin operating margins leave little room for error if costs rise or patient volumes slow.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.0% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+15.4% YoY

YoY Growth Rate

Steady EPS growth

R&D Spend

$0/ year

Declining (-100% vs prior year)

0.0% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

12.7%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$83M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Winston looking curious
Growth context

Medicover AB (publ) is growing revenue at 8% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
23.6%
Thin — 23.6% gross margin
Operating Margin
7.5%
Modest — 7.5% operating margin
ROCE
3.3%
Weak — 3.3% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+12.0%
Steady sales growth (12.0% YoY)
EPS YoY
+165.0%
Earnings growing fast (165.0% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
400%
Turns 400% of profit into real cash
FCF Margin
6.7%
Modest free cash flow (6.7%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
1.58
Elevated debt (1.58)
Interest Cover
2.55x
Tight — interest eats into profit (2.5x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio
33.4x
Pricey — P/E 33.4

P/E above the market average. People are paying up for expected growth.

P/E vs Forward
-158.5
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
1.05%
Small dividend — 1.05% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend Growth
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial